Engineering microRNA responsiveness to decrease virus pathogenicity

Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1–2. Cell 129, 303–317 (2007).

Zhang, B., Pan, X., Cobb, G.P. & Anderson, T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1–12 (2007).

van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575–579 (2007).

Lagos-Quintana, M. et al. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735–739 (2002).

Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).

Kelly, E. & Russell, S.J. History of oncolytic viruses: genesis to genetic engineering. Mol. Ther. 15, 651–659 (2007).

Aghi, M. & Martuza, R.L. Oncolytic viral therapies—the clinical experience. Oncogene 24, 7802–7816 (2005).

Thorne, S.H., Hermiston, T. & Kirn, D. Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects. Semin. Oncol. 32, 537–548 (2005).

Brown, B.D., Venneri, M.A., Zingale, A., Sergi Sergi, L. & Naldini, L. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 12, 585–591 (2006).

Gottwein, E., Cai, X. & Cullen, B.R. A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing. J. Virol. 80, 5321–5326 (2006).

Schiff, G.M. & Sherwood, J.R. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J. Infect. Dis. 181, 20–26 (2000).

Dekel, B., Yoeli, R., Shulman, L., Padeh, S. & Passwell, J.H. Localized thigh swelling mimicking a neoplastic process: involvement of coxsackie virus type A21. Acta Paediatr. 91, 357–359 (2002).

Knipe, D.M. et al. Fields Virology, 5th Edition. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses Ch. 25 (Lippincott, Williams and Wilkins, Philadelphia, 2007).

Skelding, K.A., Barry, R.D. & Shafren, D.R. Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21. Breast Cancer Res. Treat. published online, doi:10.1007/s10549-008-9899-2 (7 February 2008).

Au, G.G., Lindberg, A.M., Barry, R.D. & Shafren, D.R. Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21. Int. J. Oncol. 26, 1471–1476 (2005).

Baskerville, S. & Bartel, D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241–247 (2005).

Brown, B.D. et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25, 1457–1467 (2007).

Nelson, P.T. et al. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat. Methods 1, 155–161 (2004).

Rao, P.K., Kumar, R.M., Farkhondeh, M., Baskerville, S. & Lodish, H.F. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. USA 103, 8721–8726 (2006).

Rohll, J.B., Moon, D.H., Evans, D.J. & Almond, J.W. The 3′ untranslated region of picornavirus RNA: features required for efficient genome replication. J. Virol. 69, 7835–7844 (1995).

Dufresne, A.T. & Gromeier, M. A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice. Proc. Natl. Acad. Sci. USA 101, 13636–13641 (2004).

Domingo, E., Menendez-Arias, L. & Holland, J.J. RNA virus fitness. Rev. Med. Virol. 7, 87–96 (1997).

Alonso, M.M. et al. Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo. Cancer Gene Ther. 14, 756–761 (2007).

Hingorani, M. et al. Combining radiation and cancer gene therapy: a potential marriage of physical and biological targeting? Curr. Cancer Drug Targets 7, 389–409 (2007).

Qiao, J. et al. Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat. Med. 14, 37–44 (2008).

Barber, G.N. Vesicular stomatitis virus as an oncolytic vector. Viral Immunol. 17, 516–527 (2004).

Qiao, J. et al. Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. Clin. Cancer Res. 14, 259–269 (2008).

Heise, C.C., Williams, A.M., Xue, S., Propst, M. & Kirn, D.H. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy. Cancer Res. 59, 2623–2628 (1999).

Roberts, L. Infectious disease. Vaccine-related polio outbreak in Nigeria raises concerns. Science 317, 1842 (2007).

Grimm, D. & Kay, M.A. Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol. Ther. 15, 878–888 (2007).

Parato, K.A., Senger, D., Forsyth, P.A. & Bell, J.C. Recent progress in the battle between oncolytic viruses and tumours. Nat. Rev. Cancer 5, 965–976 (2005).